Metabolic complications of protease inhibitors: what have we learned so far?

The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service

Volumn 11, Issue 2, 1999, Pages

  Erbelding, E J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE INHIBITOR;

ARTICLE; CHEMICALLY INDUCED DISORDER; CORONARY ARTERY DISEASE; DRUG COMBINATION; GLUCOSE INTOLERANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; LIPODYSTROPHY; METABOLISM; ORGANIZATION; UNITED STATES;

CHICAGO; CONGRESSES; CORONARY DISEASE; DRUG THERAPY, COMBINATION; GLUCOSE INTOLERANCE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; HYPERLIPIDEMIAS; LIPODYSTROPHY;

EID: 0033085530     PISSN: 15518396     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)